Advancing the World of Health

2014 BD launched the first FDA-approved drug coated balloon for peripheral artery disease. 2015 BD became the first to integrate IV pumps খেলা88 with electronic health records.\r\n 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized.\r\n

• 1954 Production of the first disposable syringes to be used in the Salk Polio vaccine trial takes place.
• 1987 BD built a plant to manufacture diagnostic products in Fukushima, Japan.
• Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare.
• 1940 BD launched the first sterilization technology for devices.
• Through continuous innovation and strategic leadership, we empower biopharma partners to launch faster, grow reliably, and deliver better outcomes.

Health and safety issues

This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard. In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock. Later Retractable would claim BD was falsely advertising its own brand of retractable needle as the “world’s sharpest needle”.

BD is advancing the world of health™ and you can help shape what comes next

1956 BD enters the Brazilian syringe market and quickly becomes the largest provider in the country with two modern plants and HQ in Sao Paulo. 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles. 1981 A new plant is built in Plymouth, England to manufacture BD Vacutainer® system products and serve a growing European market. 1987 BD built a plant to manufacture diagnostic products in Fukushima, Japan. 1999 The world’s shortest, thinnest insulin pen needle is introduced.

In certain places, BD Medical also offers consulting and analytics related services. In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion. In July 2021, BD announced it would acquire surgical scaffold maker Tepha, after having acquired Velano Vascular earlier the same month.

Retractable would accuse BD of patent infringement after BD released a retractable needle of its own. The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson. We know that possibilities are endless when people feel supported and inspired.